Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Myelodysplastic Syndromes 7Myeloproliferative Disorders 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hematologic Neoplasms 3Lymphoma, Non-Hodgkin 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Graft vs Host Disease 2Ganglioneuroblastoma 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Teratoma 1Recurrence 1Neuroblastoma 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Mast-Cell 1Leukemia, Lymphoid 1Leukemia, Large Granular Lymphocytic 1Leukemia 1High Risk Myeloid Malignancies 1GATA2 Deficiency 1

Interventions

Azacitidine 13Cyclophosphamide 10venetoclax 9fludarabine phosphate 7fludarabine 7Whole-Body Irradiation 7Biopsy 7Specimen Handling 6Mycophenolic Acid 6Injections 6Decitabine 6Tacrolimus 5Cytarabine 5Busulfan 5decitabine and cedazuridine drug combination 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Cyclosporine 4cedazuridine 3X-Rays 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3olutasidenib 2Vorinostat 2Sirolimus 2Rituximab 2Melphalan 2Magnetic Resonance Spectroscopy 2Lenalidomide 2Idarubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Chronic × Thiotepa × 90 days × Clear all
NCT07588594 2026-05-26

Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia

Peking University People's Hospital

Phase NA Recruiting
31 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡